Luye Pharma Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Luye Pharma Group - overview
Established
1994
Location
Yantai, Shandong, China
Primary Industry
Pharmaceuticals
About
Established in 1994 and based in Yantai, China, Luye Pharma Group is a pharmaceutical company, which is a member of Luye Life Sciences Group. It has 8 manufacturing sites in Yantai, Nanjing, Beijing, Luzhou, Chengdu, and Germany. In 2014, it was listed on the Hong Kong Stock Exchange with stock code 02186. In 2020, it acquired Boan to accelerate development in the field of biopharmaceuticals.
In 2023, the Goserelin Microspheres for Injection Baituowei received marketing approval in China for the treatment of prostate cancer. The company's products cover the central nervous system, oncology, cardiovascular, metabolism, and other therapeutic areas, which include Rykindo, Ruoxinlin, Rivastigmine Transdermal Patch, Baituowei, etc. Its products cover more than 80 countries and regions worldwide including China, the US, Europe, and Japan. In 2022, the company's operating revenue was CNY 669.
762 million and the net profit was CNY 593. 296 million.
Current Investors
Hillhouse Investment
Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Chiropractic, Orthopedic & Physical Therapy, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.luye.cn
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Luye Pharma Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Luye Pharma Group | - | ||||||||
| Private Placement/Follow on | Completed | Luye Pharma Group | - | ||||||||
| Add-on, Trade Sale | Completed | Acino International AG's transdermal patch and implant businesses | - | ||||||||
| Private Placement/Follow on | Completed | Luye Pharma Group | - | ||||||||
| Private Placement/Follow on | Completed | Luye Pharma Group | - |
Displaying 1 - 5 of 10
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.